ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,259Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 244

$1.44M Total Retail Price of All Prescriptions

Rank: 4 out of 244

561 Patients Receiving at Least One Drug in Part D
16%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 561 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

2% of this provider’s 561 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

5% of this provider’s 1,331 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$141 was the average price of a prescription from this provider, compared to $141 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
RISPERIDONE 641 111 1 2
TRAZODONE HCL 548 47 2 1
FLUOXETINE HCL 464 55 3 13
CITALOPRAM HBR 447 24 4 6
ABILIFY 407 32 5 5
VENLAFAXINE HCL ER 394 65 6 9
QUETIAPINE FUMARATE 392 50 7 3
SERTRALINE HCL 333 60 8 7
LAMOTRIGINE 315 36 9 12
OLANZAPINE 302 37 10 8
BENZTROPINE MESYLATE 287 40 R 11 17
DIVALPROEX SODIUM 269 42 12 25
CLOZAPINE 265 20 13 4
DIVALPROEX SODIUM ER 241 14 14 16
CYMBALTA 237 14 15 10
HALOPERIDOL 236 47 16 29
LITHIUM CARBONATE 219 42 17 22
BUPROPION HCL SR 199 27 18 24
BUSPIRONE HCL 193 14 19 18
PROPRANOLOL HCL 163 15 20 36
BUPROPION XL 147 30 21 11
SEROQUEL 146 21 22 19
ZOLPIDEM TARTRATE 129 20 23 15
PAROXETINE HCL 126 84 24 23
MIRTAZAPINE 123 50 25 14
INVEGA 120 13 26 54
ZIPRASIDONE HCL 105 0 27 26
ESCITALOPRAM OXALATE 97 0 28 20
METHYLPHENIDATE HCL 97 0 28 38
RISPERDAL CONSTA 94 0 30 28
OLANZAPINE ODT 91 0 31 87
GABAPENTIN 85 0 32 21
LUNESTA 84 0 33 37
PERPHENAZINE 74 0 34 51
AMPHETAMINE SALT COMBO 71 0 S2 35 30
TOPIRAMATE 68 0 36 27
DOXEPIN HCL 67 33 37 49
AMITRIPTYLINE HCL 64 17 R 38 50
TRIHEXYPHENIDYL HCL 61 0 R 39 58
LOXAPINE 61 0 39 63
DEXTROAMPHETAMINE-AMPHETAMINE 59 0 S2 41 40
NORTRIPTYLINE HCL 58 0 42 59
HYDROXYZINE PAMOATE 57 0 R 43 32
SUBOXONE 55 0 44 67
CARBAMAZEPINE 54 12 45 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.